Stago’s D-Dimer test
The first assay to meet the new CLSI H59-A* standards for exclusion of pulmonary embolism 03/09/2014 – Stago has received approval from the US Food and Drug Administration (FDA) for the reagent STA® –Liatest® D-Di, in the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit. FDA […]
